XML 92 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Certain Financial Statement Information
12 Months Ended
Mar. 31, 2015
Certain Financial Statement Information [Abstract]  
Certain Financial Statement Information
Certain Financial Statement Information

Accounts receivable, net:
 
March 31,
 
2015
 
2014
 
(In thousands)
Accounts receivable
$
12,709

 
$
25,629

Less: allowance for bad debts
(302
)
 
(451
)
 
$
12,407

 
$
25,178


Inventories, net:
 
March 31,
 
2015
 
2014
 
(In thousands)
Finished goods
$
15,310

 
$
9,375

Work in process
5,377

 
6,510

Raw materials
2,827

 
3,061

 
$
23,514

 
$
18,946


Other current assets:
 
March 31,
 
2015
 
2014
 
(In thousands)
Prepaid expenses
$
14,847

 
$
10,978

Executive deferred compensation assets
1,004

 
1,035

Proceeds receivable from sale of strategic investment

 
3,353

Other
989

 
1,433

 
$
16,840

 
$
16,799


Property and equipment:
 
Useful
Life
 
March 31,
 
2015
 
2014
 
(In years)
 
(In thousands)
Machinery and equipment*
3-5
 
$
37,286

 
$
44,503

Leasehold improvements
1-5
 
9,909

 
11,574

Computers, office furniture and equipment*
3-5
 
32,902

 
43,365

 
 
 
80,097

 
99,442

Less: accumulated depreciation and amortization*
 
 
(63,348
)
 
(78,696
)
 
 
 
$
16,749

 
$
20,746


*
During the fiscal year ended March 31, 2015, the Company wrote-off fully depreciated assets with an acquired cost of $24.0 million. Also the Company wrote-off of a capitalized mask of $2.6 million as a result of recent restructuring. Refer to Note 7, Restructuring, to the Consolidated Financial Statements for additional information.

 
Goodwill and purchased intangibles:
Goodwill is as follows:
 
March 31,
 
2015
 
2014
 
(In thousands)
Goodwill
$
11,425

 
$
11,425



Purchase-related intangibles are as follows: 
 
March 31, 2015
 
March 31, 2014
 
Gross
 
Accumulated
Amortization
and
Impairments
 
Net
 
Weighted
average
remaining
useful life
 
Gross
 
Accumulated
Amortization
and
Impairments
 
Net
 
Weighted
average
remaining
useful life
 
(In thousands)
 
(In years)
 
(In thousands)
 
(In years)
Developed technology/in-process research and development
$
425,000

 
$
(425,000
)
 
$

 
0.0
 
$
425,000

 
$
(425,000
)
 
$

 
0.0
Customer relationships
6,330

 
(6,330
)
 

 
0.0
 
6,330

 
(6,225
)
 
105

 
0.4
Patents/core technology rights/trade name
62,306

 
(62,306
)
 

 
0.0
 
62,306

 
(62,306
)
 

 
0.0
 
$
493,636

 
$
(493,636
)
 
$

 
 
 
$
493,636

 
$
(493,531
)
 
$
105

 
 


Other Assets:
 
March 31,
 
2015
 
2014
 
(In thousands)
Non-current portion of prepaid expenses
$
1,974

 
$
4,235

Strategic investments*

 
3,000

Other
$
596

 
$
519

 
$
2,570

 
$
7,754



*During the fiscal year ended March 31, 2015, the Company recorded other-than-temporary impairment charges of $3.0 million with respect to two of its strategic investments. Refer to Note 1, Summary of Significant Accounting Policies, to the Consolidated Financial Statements for details.

Other accrued liabilities:
 
March 31,
 
2015
 
2014
 
(In thousands)
Employee related liabilities
$
1,454

 
$
1,733

Executive deferred compensation
1,025

 
1,314

Income taxes
1,311

 
962

Professional fees
515

 
1,259

Other
3,339

 
5,609

 
$
7,644

 
$
10,877


Warranty Reserves:
The Company’s products typically carry a one-year warranty. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized. Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates, use of materials and service delivery costs incurred in correcting any product failure. Should actual product failure rates, use of materials or service delivery costs differ from the Company’s estimates, additional warranty reserves could be required, which could reduce its gross margin.
The following table summarizes warranty reserve activity:
 
March 31,    
 
2015
 
2014
 
(In thousands)
Beginning balance
$
199

 
$
220

Additions during the period
85

 
58

Settlements and expirations
(121
)
 
(79
)
Change in estimates
31

 

Ending balance
$
194

 
$
199


Net realized gain on short-term investments and interest income, net:
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
 
(In thousands)
Net realized gain on short-term investments
1,353

 
3,360

 
1,391

Interest income, net
1,411

 
1,692

 
2,347

Impairments of short-term investments and marketable securities

 

 
(1,143
)
 
$
2,764

 
$
5,052

 
$
2,595



Other (expense) income, net:
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
 
(In thousands)
Impairment of strategic investments
$
(3,000
)
 
$

 
$
(2,250
)
Impairment of notes receivable and other assets

 

 
(1,800
)
Net (loss) gain on disposals of property
(27
)
 
67

 
(21
)
Other, net
(29
)
 
287

 
1,677

 
$
(3,056
)
 
$
354

 
$
(2,394
)


Net loss per share:
Shares used in basic net loss per share are computed using the weighted average number of common shares outstanding during each period. Shares used in diluted net loss per share include the dilutive effect of common shares potentially issuable upon the exercise of stock options and vesting of RSUs. The reconciliation of shares used to calculate basic and diluted net loss per share consists of the following (in thousands, except per share data):
 
 
Fiscal Years Ended March 31,
 
2015
 
2014
 
2013
Net loss
$
(52,058
)
 
$
(5,694
)
 
$
(134,115
)
Shares used in net loss per share computation:
 
 
 
 
 
Weighted average common shares outstanding, basic
78,814

 
72,897

 
65,258

Net effect of dilutive common share equivalents

 

 

Weighted average common shares outstanding, diluted
78,814

 
72,897

 
65,258

Basic and diluted net loss per share
$
(0.66
)
 
$
(0.08
)
 
$
(2.06
)

The effect of dilutive securities (comprised of options and RSUs) totaling 1.4 million, 1.5 million and 0.8 million shares for the fiscal years ended March 31, 2015, 2014 and 2013, respectively, has been excluded from the diluted net loss per share computation since the Company incurred losses in the periods presented and their effect would be antidilutive.